Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Thrombosis Research|September 12, 2017
Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French studyIsabelle Gouin-Thibault, Geneviève Freyburger, Emmanuel de Maistre, et al.Drugs & Aging|January 20, 2007
Elderly medical patients treated with prophylactic dosages of enoxaparin: influence of renal function on anti-Xa activity levelIsabelle Mahe, Isabelle Gouin-Thibault, Ludovic Drouet, et al.International Journal of Laboratory Hematology|December 28, 2020
Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 monthsGeoffrey Foulon-Pinto, Georges Jourdi, Julien Perrin, et al.Journal of Clinical Pathology|February 5, 2017
Ticagrelor reversal: <i>in vitro</i> assessment of four haemostatic agentsLeyla Calmette, Anne-Céline Martin, Bernard Le Bonniec, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|October 18, 2024
Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical PointsIsabelle Gouin-Thibault, Alexandre Mansour, Michael Hardy, et al.Annales De Biologie Clinique|June 4, 2024
[Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes]Sophie Melicine, Laure Maucorps, Valérie Eschwège, et al.Annales De Biologie Clinique|June 11, 2011
[Hodgkin lymphoma in the elderly]Tiphaine Belleville, Samir Bouhadiba, Juliette Fontaine, et al.Journal of Thrombosis and Haemostasis : JTH|May 20, 2026
How to monitor and manage unfractionated heparin in practice (Part 1): Guidance from the SSC of the ISTHIsabelle Gouin-Thibault, Corinne Frere, Lana A Castellucci, et al.Annales De Biologie Clinique|December 5, 2012
Anemia in the elderly: usefulness of an easy and comprehensive laboratory screenEric Pautas, Virginie Siguret, Thi Mai Anh Kim, et al.International Journal of Laboratory Hematology|September 14, 2023
Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC-MS for plasma level dabigatran quantification: Results from DRIVING studyAmbre de Fautereau-Vassel, Antoine Mokhtarian, Manon Mangenot, et al.Pageof 9